Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for ''
published presentations and documents on DocSlides.
FDA Perspective on the development and use of
by osullivan
Epidemiological cut-off values (ECVs). Simone M. S...
FDA’s New Final Guidance on
by pasty-toler
Drug Inspections. Anne K. Walsh. FDLI Enforcement...
Pharmacometrics and Biostatistics Interactions at the FDA
by byrne
Jeffry Florian, Ph.D.. Division of Pharmacometrics...
FDA Pre-Submission Meetings
by violet
for 510(k) Submissions. Consultants and RA Experts...
SHEDDING LIGHT ON AN FDA VISIT
by CuteAsACupcake
Joyce Nancarrow Tull, MSN, RN, CCRP. University of...
FDA's role in the innovation and
by josephine
evaluation of evolving . computer-aided diagnosis ...
FDA’s Center for Devices and Radiological Health: Current Status and Future Direction
by carny
Jeff Shuren, MD, JD. Center for Devices and Radiol...
Sponsor-Investigator (SI) FDA Inspections
by eurolsin
Christiana Provencal, M.A.. Quality Assurance / Qu...
THE FDA WEBSITE
by min-jolicoeur
IMPROVING. TRANSPARENCY. AND EFFECTIVENESS. Steph...
Post-FDA Approval, Initial US Clinical Experience with Watc
by phoebe-click
Vivek Y. Reddy MD. 1. *, Douglas N. Gibson MD. 2....
FDA Regulation of Menthol in Tobacco Products
by pamella-moone
Patricia Kovacevic. Director, Regulatory . Aff...
Clinical Trial Data Integrity:
by phoebe-click
Bi. oresearch . Mo. nitoring Program. Jur Strobos...
Building Our Information
by madison
+ Data. Future. The NLM Update – Part 2. Betsy ...
the FC the control
by payton
PMA P080002: FDA Summary of Safety and Effectivene...
Patient Engagement in Drug Development
by debby-jeon
:. Experiences, Good Practices and Lessons Learne...
FDA Public Workshop – Variant Classification
by lindy-dunigan
Session 4: Future directions for data sharing, st...
FDA 21 CFR Part 11 Compliance
by debby-jeon
Charles Yan, PhD. Senior Director, Clinical Data ...
ACE Presentation for Industry
by natalia-silvester
Office of Enforcement and Import Operations. Food...
ACE Presentation for Industry
by danika-pritchard
Office of Enforcement and Import Operations. Food...
Logistics Challenges
by cheryl-pisano
The New Dimensions. ITDS: . Are the PGA Data Sets...
It is the policy of the University of Arkansas for Med
by ellena-manuel
All individuals who are in a position to con...
Registry Kobayashi Cardiology Childrens Hospital Associate Professor
by nathanael
How Are They Set Up?. Daisuke Kobayashi, MD, MPH, ...
Perspectives on the Animal Rule
by mia
What is the Animal Rule?. The Basics. J.E. Estep, ...
U.S. Regulatory implementation of estimand framework: Background and status
by elysha
John Scott, Ph.D., FDA/CBER/OBE. Joint PSI, EFSPI...
A Bayesian Approach in Design and Analysis of Pediatric Cancer Clinical Trials
by adah
Jingjing Ye, PhD. BeiGene. PSI Journal Club: Bayes...
Drug Availability Reporting and Expectations
by bitsy
(. iDare. ). Melanie Singh. Problem. 2022 ended wi...
Writing and Holding an IND- IIT Development
by osullivan
Week 3- Proposing and Conducting a Clinical Trial....
Accelerated Partnering
by bery
for Effective Recalls Recall Modernization: E ven ...
Department of Health and Human Services
by daisy
FDADaniel R. LevinsonInspector General OEI-0...
Al Crouse, CVRx ; Owen Faris, FDA; Ravi Nabar, Illumina;
by adia
Joseph Sapiente, MDIC; Sara Sulfridge, Baxter. Apr...
Clinical and Nonclinical Inspections
by claire
n and Research or CBER conducting clinical resear...
Department of Health and Human Services2 OFFICE OF 2INSPECTOR GENERAL
by anastasia
Daniel R LevinsonInspector General The mission of ...
1 Pediatric Clinical Investigator Training
by lois-ondreau
GCP: . Tips on Clinical Trial Conduct and . Prepa...
SHEDDING LIGHT ON AN
by olivia-moreira
SHEDDING LIGHT ON AN FDA VISIT Joyce Nancarrow Tu...
IT Strategic Plan Todd Simpson, Chief Information Officer, FDA
by pamella-moone
May 16, 2017. Welcome!. 2. nd. Annual OIMT Outre...
41 st
by yoshiko-marsland
NCBFAA Annual Conference. . CAPT. Domenic J. Ve...
FDA Tree Nut Risk Assessment
by alexa-scheidler
and Human Salmonellosis. National Pecan . Sheller...
Trans-Atlantic regulatory
by tawny-fly
cooperation and harmonisation. Focus . on . IDMP:...
Future Directions in Symptom-Driven Consumer Applications
by danika-pritchard
Ed Daniels. mHealth Networking . Conference. Maki...
Summary of FDA and NIST efforts toward metrics and standard
by tatiana-dople
. Content by . Marc . Salit. & Justin . Zoo...
Load More...